Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BGLC NASDAQ:BRTX OTCMKTS:CBAI OTCMKTS:MITI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBGLCBioNexus Gene Lab$5.19-3.5%$5.45$2.01▼$15.60$9.67M5.2177,638 shs28,960 shsBRTXBiorestorative Therapies$1.62-3.0%$1.54$1.19▼$2.55$13.32M-0.6978,818 shs56,535 shsCBAICBA Florida$0.01+1.3%$0.01$0.01▼$0.01$9.91MN/A2.73 million shs19.77 million shsMITIMitesco$0.19-3.3%$0.19$0.00▼$0.78$2.94M2.1776,455 shs43,158 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBGLCBioNexus Gene Lab-3.53%-1.89%+18.76%+1.96%+26.59%BRTXBiorestorative Therapies-2.99%+8.00%+3.18%0.00%0.00%CBAICBA Florida0.00%0.00%0.00%0.00%0.00%MITIMitesco-5.00%-22.45%-5.05%-36.43%-68.33%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBGLCBioNexus Gene Lab$5.19-3.5%$5.45$2.01▼$15.60$9.67M5.2177,638 shs28,960 shsBRTXBiorestorative Therapies$1.62-3.0%$1.54$1.19▼$2.55$13.32M-0.6978,818 shs56,535 shsCBAICBA Florida$0.01+1.3%$0.01$0.01▼$0.01$9.91MN/A2.73 million shs19.77 million shsMITIMitesco$0.19-3.3%$0.19$0.00▼$0.78$2.94M2.1776,455 shs43,158 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBGLCBioNexus Gene Lab-3.53%-1.89%+18.76%+1.96%+26.59%BRTXBiorestorative Therapies-2.99%+8.00%+3.18%0.00%0.00%CBAICBA Florida0.00%0.00%0.00%0.00%0.00%MITIMitesco-5.00%-22.45%-5.05%-36.43%-68.33%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBGLCBioNexus Gene Lab 1.00SellN/AN/ABRTXBiorestorative Therapies 1.00SellN/AN/ACBAICBA Florida 0.00N/AN/AN/AMITIMitesco 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest MITI, BRTX, CBAI, and BGLC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/8/2025BGLCBioNexus Gene LabWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025BRTXBiorestorative TherapiesWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025BGLCBioNexus Gene LabWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025BRTXBiorestorative TherapiesWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)(Data available from 10/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBGLCBioNexus Gene Lab$9.51M0.98N/AN/A$4.63 per share1.12BRTXBiorestorative Therapies$400K32.32N/AN/A$1.23 per share1.32CBAICBA FloridaN/AN/AN/AN/AN/AN/AMITIMitesco$40K71.11N/AN/A($2.70) per share-0.07Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBGLCBioNexus Gene Lab-$1.60MN/A0.00∞N/A-30.70%-35.54%-29.08%N/ABRTXBiorestorative Therapies-$8.98M-$1.27N/AN/AN/A-1,772.40%-137.00%-88.31%11/11/2025 (Estimated)CBAICBA Florida-$40KN/A0.00∞N/AN/AN/AN/AN/AMITIMitesco-$2.51MN/A0.00∞N/A1,639.45%N/A-744.83%N/ALatest MITI, BRTX, CBAI, and BGLC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/18/2025Q2 2025BGLCBioNexus Gene LabN/A-$0.34N/A-$0.34N/A$2.26 million8/13/2025Q2 2025MITIMitescoN/A-$0.01N/A-$0.01N/A$0.02 million8/12/2025Q2 2025BRTXBiorestorative Therapies-$0.41-$0.30+$0.11-$0.30$0.34 million$0.30 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBGLCBioNexus Gene LabN/AN/AN/AN/AN/ABRTXBiorestorative TherapiesN/AN/AN/AN/AN/ACBAICBA FloridaN/AN/AN/AN/AN/AMITIMitescoN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBGLCBioNexus Gene LabN/A3.632.94BRTXBiorestorative TherapiesN/A2.072.07CBAICBA FloridaN/AN/AN/AMITIMitescoN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBGLCBioNexus Gene Lab18.85%BRTXBiorestorative Therapies69.38%CBAICBA FloridaN/AMITIMitesco0.01%Insider OwnershipCompanyInsider OwnershipBGLCBioNexus Gene Lab0.70%BRTXBiorestorative Therapies30.80%CBAICBA Florida30.00%MITIMitesco4.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBGLCBioNexus Gene Lab301.80 million1.78 millionNot OptionableBRTXBiorestorative Therapies77.98 million5.52 millionNot OptionableCBAICBA Florida21.27 billion890.45 millionNot OptionableMITIMitesco3014.97 million14.24 millionNot OptionableMITI, BRTX, CBAI, and BGLC HeadlinesRecent News About These CompaniesMitesco (OTCMKTS:MITI) Shares Down 8.2% - Time to Sell?October 9 at 2:43 AM | americanbankingnews.comMitesco Expands A.I. Based Sales Automation to Include Mortgage, Insurance IntegrationOctober 1, 2025 | finance.yahoo.comMitesco Expands Operations with New InitiativesSeptember 23, 2025 | tipranks.comMitesco Announces New Managed Services Offerings, Expanded Application Software Team and Addition of Digital Currency ExpertsSeptember 18, 2025 | theglobeandmail.comMitesco’s Centcore Partners with Sportzfolio for Pickleball PlatformSeptember 9, 2025 | tipranks.comMitesco Highlights Strategic Expansion in Data Center Operations and Launch of AI-Powered Sales Automation PlatformAugust 19, 2025 | finance.yahoo.comMitesco Advances on Robo-Agent A.I. Project for Sales Automation, Follow-up-Boss Integration, Major Agencies Engaged in Test BedJune 18, 2025 | finance.yahoo.comSentry RMS by Accucom Chooses Centcore Data Center for Cloud InstallationJune 10, 2025 | finance.yahoo.comMitesco Expands Board, Updates on Centcore Data Services and New A.I. ApplicationsMay 30, 2025 | theglobeandmail.comEQS-News: Mitesco Expands Board, Updates on Centcore Data Services and New A.I. ApplicationsMay 29, 2025 | finanzen.atFEQS-News: Mitesco, Inc. and United Powers, LLC Enter Strategic VAR PartnershipApril 2, 2025 | markets.businessinsider.comMitesco, Inc. and United Powers, LLC Enter Strategic VAR PartnershipApril 2, 2025 | finance.yahoo.comEQS-News: Mitesco Reports on Business Developments in Its Centcore Data Center Services UnitFebruary 5, 2025 | markets.businessinsider.comMitesco Reports on Business Developments in Its Centcore Data Center Services UnitFebruary 5, 2025 | finance.yahoo.comMitesco announces expanded capabilities at Florida data centerDecember 18, 2024 | markets.businessinsider.comMitesco's Centcore Unit Drives Digital Transformation at State-of-the-Art Data CenterDecember 16, 2024 | globenewswire.comMitesco Reports $2 Million Q3 Profit From RestructuringDecember 2, 2024 | globenewswire.comMitesco Restructures Financial Obligations Amid Strategic ShiftNovember 23, 2024 | markets.businessinsider.comMitesco Restructures Debt and Shifts Focus to CloudNovember 19, 2024 | markets.businessinsider.comMitesco Provides Shareholder Update on Restructuring, Expansion of Its Advisory Board, and Introduction of A.I.-Based Application Software for Sales AutomationOctober 29, 2024 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMITI, BRTX, CBAI, and BGLC Company DescriptionsBioNexus Gene Lab NASDAQ:BGLC$5.19 -0.19 (-3.53%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$5.18 -0.02 (-0.29%) As of 10/10/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.Biorestorative Therapies NASDAQ:BRTX$1.62 -0.05 (-2.99%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$1.58 -0.04 (-2.16%) As of 10/10/2025 07:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. The company was incorporated in 1997 and is based in Melville, New York.CBA Florida OTCMKTS:CBAI$0.0078 +0.00 (+1.30%) As of 06/30/2020CBA Florida, Inc. does not have significant operations. Previously, the company provided private cord blood and cord tissue stem cell services. The company was formerly known as Cord Blood America, Inc. and changed its name to CBA Florida, Inc. in May 2018. CBA Florida, Inc. is based in Las Vegas, Nevada.Mitesco OTCMKTS:MITI$0.19 -0.01 (-3.31%) As of 10/10/2025 03:54 PM EasternMitesco, Inc. does not have significant operations. Previously, it was engaged in healthcare technology and services business. Mitesco, Inc. is based in Vero Beach, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom Gets Second $420 Target as CPO Win Boosts Outlook Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can Bargain Alert: DraftKings Is the Most Oversold It’s Ever Been Constellation Brands: Buffett’s $2.2B Bet May Have Hit Bottom How Gamers Are Powering Microsoft’s Next Wave of Growth AI Meets Nuclear: Palantir’s Role in Energy Expansion Buy the Dip? Zillow’s Profit Comeback Meets Market Pressure Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
